Zerodha (Trading Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Incorporated in 2020, Piramal Pharma Limited a flagship company of Piramal Group offers pharmaceutical products and services across a domestic and global distribution network.
The company has 15 global manufacturing facilities and a global distribution network in over 100 countries.
Piramal Pharma includes:
| Issue Open | August 8, 2023 - August 17, 2023 |
| Security Name | Piramal Pharma Limited |
| Issue Size (Shares) | 129,629,630 |
| Issue Size (Amount) | ₹1,050.00 Crores |
| Issue Price | ₹81 per share |
| Face Value | ₹10 per share |
| Listing At | BSE, NSE |
| Terms of Payment | The full amount of Rs. 81 for rights equity shares has to be paid on application. |
| Entitlement | 5 Rights Equity Share(s) for every 46 fully paid-up Equity Shares held on Record Date |
| Last Date to buy shares | August 1, 2023 |
| Record Date | August 2, 2023 |
| Credit of Rights Entitlements | |
| Bid/Offer Opens On | August 8, 2023 |
| Renunciation of Rights Entitlements | August 10, 2023 |
| Bid/Offer Closes On | August 17, 2023 |
| Deemed Date of Allotment | August 23, 2023 |
| Credit Date | August 24, 2023 |
| Listing Date | August 28, 2023 |
| Period Ended | 31 Mar 2021 | 31 Mar 2022 | 31 Mar 2023 |
| Assets | 10,899.78 | 12,797.04 | 14,522.56 |
| Revenue | 6,479.01 | 6,834.90 | 7,306.66 |
| Profit After Tax | 835.03 | 375.96 | -186.46 |
| Net Worth | 5,076.75 | 6,069.94 | 5,968.45 |
| Reserves and Surplus | 4,488.62 | 5,290.69 | 5,181.79 |
| Total Borrowing | 2,910.19 | 4,023.28 | 5,504.77 |
The company intends to utilize the net proceeds from the issue towards the funding of the following objects:
57 3.4 Rating:  Vote Here ... |
Piramal Pharma Limited
Ground Floor, Piramal Ananta,
Agastya Corporate Park, Kamani Junction,
LBS Marg, Kurla, Mumbai 400 070
Phone: +91 22 3802 3000
Email: shareholders.ppl@piramal.com
Website: https://www.piramal.com/
Link Intime India Private Ltd
Phone: +91-22-4918 6270
Email: ppl.rights@linkintime.co.in
Website: https://linkintime.co.in/initial_offer/public-issues.html
The Piramal Pharma Rights Issue 2023 opens on August 8, 2023, and closes on August 17, 2023.
Piramal Pharma Rights Issue 2023 Schedule
| Last Date for credit of Rights Entitlements | |
| Last Date for renunciation of Rights Entitlements | August 10, 2023 |
| Issue Opening Date | August 8, 2023 |
| Issue Closing Date | August 17, 2023 |
| Date of Allotment (on or about) | August 23, 2023 |
| Date of Credit (on or about) | August 24, 2023 |
| Date of Listing (on or about) | August 28, 2023 |
Piramal Pharma Rights Issue 2023 price is set at ₹81 per share per equity share.
The eligible shareholders are being offered 5 Rights Equity Share(s) for every 46 fully paid-up Equity Shares held on Record Date (August 2, 2023).
The record date for the Piramal Pharma Rights Issue 2023 is August 2, 2023.
The issue size of Piramal Pharma Rights Issue 2023 is of 129,629,630 equity shares at ₹81 per share aggregating upto ₹1,050.00 Crores.
The Letter of Offer for Piramal Pharma Rights Issue 2023 can be download here.
You can apply for Piramal Pharma Rights Issue 2023 in two ways:
Steps to apply for Piramal Pharma Rights Issue 2023 using Net Banking (ASBA)
Note: Your bank may not offer this facility to certain rights issues. In that case, you may have to choose the option below.
Steps to apply for Piramal Pharma Rights Issue 2023 using Registrar's website (R-WAP)
1| Link|August 16, 2023 10:12:36 AM
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
